Back to News & Events

Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support

Medisafe has raised $30 million in Series C funding with investments led by Sanofi Ventures and ALIVE Israel HealthTech Fund, joined by Leumi Partners, Menorah Mivtachim and Consensus Business Group, along with previous investors Pitango Ventures, 7Wire Ventures, Merck Ventures, Octopus Ventures, lool HealthTech, Triventures and Ourcrowd.

You may also like

Transforming Breast Cancer Care: Proven Adherence Gains for Pharma Execs

Summary Breast cancer remains one of the most prevalent malignancies worldwide, with an estimated 287,850 new invasive cases and 43,250 

..Read More

Medisafe Empowers Pharma: Elevating Cardiovascular Drug Launches

Summary The cardiovascular pharmaceutical landscape constantly encounters hurdles such as medication non-adherence and fragmented patient engagement. Medisafe’s pioneering digital solutions, 

..Read More

Revolutionizing Pharma Patient Engagement with AI: Medisafe Solutions Unveiled

Summary Revolutionary advances in artificial intelligence (AI) are dramatically transforming the pharmaceutical industry, with patient engagement emerging as a crucial 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us